SMTL ID : 3u6j.1

Crystal structure of the VEGFR2 kinase domain in complex with a pyrazolone inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x 03X: N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide(Non-covalent)

03X.1: 21 residues within 4Å: Chain A: L.26, G.27, V.34, A.52, K.54, E.71, I.74, L.75, I.78, V.84, T.102, E.103, F.104, C.105, K.106, L.155, H.162, L.171, C.181, D.182, F.183 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.52, A:E.71, A:L.75, A:L.75, A:I.78, A:V.84, A:F.104, A:L.155, A:D.182 Hydrogen bonds: A:C.105, A:D.182

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Norman, M.H. et al., Structure-based design of novel class II c-Met inhibitors: 1. Identification of pyrazolone-based derivatives. J.Med.Chem. (2012)

Release Date

2012-02-22

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2